+96%

est. 2Y upside i

Series B

Nabis is the largest licensed cannabis wholesale platform.

Rank

#473

Sector

Cannabis Technology

Est. Liquidity

~3Y

Data Quality

Data: Low

Nabis presents a high-risk, high-potential equity opportunity.

Last updated: July 21, 2026

Bull (30%)+193%

Exit multiple expands to 5x forward revenue as Nabis achieves category leadership and benefits from an IPO window, projecting $625M exit value. Net of 20% dilution, upside +192.5%.

Base (55%)+68%

Exit multiple converges to 3x forward revenue inline with public cannabis tech comps, projecting $375M exit value. Net of 20% dilution, upside +67.5%.

Bear (15%)+5%

Exit multiple compresses to 2x forward revenue due to regulatory headwinds or competition, projecting $250M exit value. Net of 20% dilution, upside +5%.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Funding Intensity

2200%

Total funding of $44M vs. estimated entry valuation of $200M gives a preference overhang of 22%, which is moderate but manageable.

Dilution Risk

moderate

Given profitability and expansion, a raise within 24 months is possible but not certain. Assumed 20% dilution.

Secondary Liquidity

none

No secondary market transactions reported; liquidity likely limited until exit.

Other — 42 roles

View all 42 open roles at Nabis →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Nabis's data — designed to show you've done your homework.

  • 1

    “How does Nabis plan to maintain its competitive moat as regulatory barriers evolve?”

  • 2

    “What is the unit economics breakdown for the marketplace vs. software vs. financing?”

  • 3

    “What is the expected timeline for an IPO or acquisition, and how will employee equity be structured?”

Community

Valuation Sentiment

Our model estimates +96% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.